Burn News and Research

RSS

Alcohol damages liver, weakens immune system, slows healing, impairs bone formation, and much more

Alcohol does much more harm to the body than just damaging the liver. Drinking also can weaken the immune system, slow healing, impair bone formation, increase the risk of HIV transmission and hinder recovery from burns, trauma, bleeding and surgery.

12 Nov 2010

Experts to discuss public health issues on using mobile health technology at 2010 mHealth Summit

As obesity rates and the cost of healthcare continue to be on the rise, the 2010 mHealth Summit in Washington D.C. is bringing together industry thought leaders, researchers, and policy makers to discuss the opportunities to address pressing public health issues utilizing mobile health technology.

10 Nov 2010

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and a financial update for the third quarter ended September 30, 2010.

9 Nov 2010

Study explains link between morbid obesity and metabolic syndrome

Scientists have found that the fat cells and tissues of morbidly obese people and animals can reach a limit in their ability to store fat appropriately. Beyond this limit several biological processes conspire to prevent further expansion of fat tissue and in the process may trigger other health problems.

9 Nov 2010

BioCryst to present data on BCX4208 for gout at ACR Scientific Meeting

BioCryst Pharmaceuticals, Inc. announced the presentation of new data related to the efficacy and safety of BCX4208 for the treatment of gout at the 74th ACR Scientific Meeting being held in Atlanta, Georgia.

9 Nov 2010

Lifestyle changes and natural supplements can control blood sugar levels

The holiday season can make it challenging for people with diabetes to keep their blood sugar levels stable. Diabetes expert, Dr. Isaac Eliaz recommends prevention through a number of lifestyle changes and natural supplements.

3 Nov 2010

ArthroCare SpeedFix Suture Anchor system granted FDA clearance

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its SpeedFix Suture Anchor system (SpeedFix™). SpeedFix, a push-in anchor made of PEEK (polyether-etherketone) polymer, is designed for the repair of certain tears of the labrum in a shoulder.

3 Nov 2010

NPS third quarter net loss increases to $15.7 million

NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today reported its results for the third quarter 2010.

2 Nov 2010

New targeted therapy shows positive results in patients with lung cancer

A UC Irvine oncologist's work with a targeted therapy is showing great promise in patients with a deadly form of lung cancer. The results were published Thursday in the New England Journal of Medicine.

2 Nov 2010

Parents need to protect time children need to sleep

We all know that pulling all-nighters, being overly caffeinated and overly stimulated have become a part of college life, but the reality is that even as school-age children are dealing with these scenarios.

2 Nov 2010

Access Pharmaceuticals receives $1.5 million in government grants

ACCESS PHARMACEUTICALS, INC. a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has been awarded $1.5 million in government grants.

2 Nov 2010

EHSI President seeks new medical technologies and investment opportunities in Poland

Emerging Healthcare Solutions President and CEO Cindy Morrissey is in Poland this week to seek out new medical technologies and investment opportunities for the company.

30 Oct 2010

CSL Behring creates Interlaken Leadership Awards to support innovative immunoglobulin research

To demonstrate its continued commitment to innovative immunoglobulin (Ig) research, CSL Behring announced today it has created the Interlaken Leadership Awards. This global awards program will provide monetary grants to advance medical research and knowledge about the potential role of immunoglobulin therapy in the treatment of neurologic disorders.

29 Oct 2010

Long hours and nights on call lead to surgeon distress

Just as with everyone else perhaps, the more hours surgeons work, and the more nights they spend on call each week, the more likely they are to face burn-out, depression, dissatisfaction with their careers and serious work-home conflicts, according to a major new study led by Johns Hopkins and Mayo Clinic researchers.

29 Oct 2010

Pain Therapeutics third quarter net loss decreases from $1.3 million to $1.0 million

Pain Therapeutics, Inc. a biopharmaceutical company, today reported financial results for its third quarter of fiscal year 2010.

29 Oct 2010

FDA clears ArthroCare's Spartan PEEK Suture Implant system

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Spartan PEEK Suture Implant system (Spartan™). Spartan is a preloaded PEEK threaded anchor indicated for use in fixation of soft tissue to bone, such as during a rotator cuff repair.

28 Oct 2010

Antigenics third quarter net loss decreases from $10.8 million to $5.9 million

Antigenics Inc. reported today its results for the quarter ended September 30, 2010. The company incurred a net loss attributable to common stockholders of $5.9 million, or $0.06 per share, basic and diluted, for the third quarter of 2010, compared with a net loss attributable to common stockholders of $10.8 million, or $0.13 per share, basic and diluted, in the third quarter of 2009.

28 Oct 2010

BioCryst 2010 third quarter revenue increases from $10.5 million to $12.0 million

BioCryst Pharmaceuticals, Inc. announced financial results for the third quarter and nine months ended September 30, 2010.

28 Oct 2010

Shionogi receives expanded approval for pediatric use of i.v. peramivir in Japan

BioCryst Pharmaceuticals, Inc. announced that its partner, Shionogi & Co., Ltd. has received approval for an additional indication for use of intravenous (i.v.) peramivir to treat children and infants with influenza in Japan. In January 2010, Shionogi received the world's first approval for i.v. peramivir and launched it under the commercial name RAPIACTA® in Japan.

27 Oct 2010

Tips to maintain healthy weight through Halloween and holidays

For many people, the scariest part of every Halloween is not a visit from ghouls and ghosts, but the chocolaty temptation of crunchy candy bars and sweet treats that surround us in stores, at work - even in our own homes. And sometimes it can be just too hard to resist. In fact, the average American will spend more than $20 on candy treats this Halloween, according to the National Retail Federation's 2010 Halloween Consumer Intentions and Actions Survey.

27 Oct 2010

Burn News and Research

Alcohol damages liver, weakens immune system, slows healing, impairs bone formation, and much more

Experts to discuss public health issues on using mobile health technology at 2010 mHealth Summit

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Study explains link between morbid obesity and metabolic syndrome

BioCryst to present data on BCX4208 for gout at ACR Scientific Meeting

Lifestyle changes and natural supplements can control blood sugar levels

ArthroCare SpeedFix Suture Anchor system granted FDA clearance

NPS third quarter net loss increases to $15.7 million

New targeted therapy shows positive results in patients with lung cancer

Parents need to protect time children need to sleep

Access Pharmaceuticals receives $1.5 million in government grants

EHSI President seeks new medical technologies and investment opportunities in Poland

CSL Behring creates Interlaken Leadership Awards to support innovative immunoglobulin research

Long hours and nights on call lead to surgeon distress

Pain Therapeutics third quarter net loss decreases from $1.3 million to $1.0 million

FDA clears ArthroCare's Spartan PEEK Suture Implant system

Antigenics third quarter net loss decreases from $10.8 million to $5.9 million

BioCryst 2010 third quarter revenue increases from $10.5 million to $12.0 million

Shionogi receives expanded approval for pediatric use of i.v. peramivir in Japan

Tips to maintain healthy weight through Halloween and holidays

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News